Clinical trial / 2004
Oral aloe vera failed to lessen radiation-induced mucositis in head-and-neck neoplasms.
A double-blind trial assigned 58 head-and-neck cancer patients undergoing curative radiation therapy to receive oral aloe vera gel or a placebo. At treatment conclusion, both cohorts demonstrated statistically indistinguishable maximal toxicity grades, mucositis duration, pain medication usage, weight changes, and quality-of-life scores. Oral aloe vera did not decrease mucosal soreness, diminish oral tissue inflammation, or improve radiotherapy tolerance.
- Study type
- Randomized double-blind trial
- Who was studied
- 58 patients with head-and-neck cancer receiving curative radiotherapy
- What was measured
- mucositis severity, quality of life, and treatment toxicity
THE PAPER
Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.
Su CK, Mehta V, Ravikumar L, Shah R, Pinto H, Halpern J, Koong A, Goffinet D, Le QT. Int J Radiat Oncol Biol Phys, 2004.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.